Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.06 CAD
Change Today 0.00 / 0.00%
Volume 0.0
MDX On Other Exchanges
As of 1:13 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

medx health corp (MDX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/28/14 - C$0.13
52 Week Low
01/22/15 - C$0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDX HEALTH CORP (MDX)

Related News

No related news articles were found.

medx health corp (MDX) Related Businessweek News

No Related Businessweek News Found

medx health corp (MDX) Details

MedX Health Corp. develops, manufactures, and distributes phototherapy devices. Its products comprise MedX phototherapy devices, MedX rehab console systems, MedX rehab handheld lasers, MedX SLD clusters, MedX rehab portable lasers, MedX dental console systems, MedX Oralase (dental) portable lasers, MedXHOME systems, MedX acupuncture console laser systems, and MedX acupuncture portable lasers. The company also provides MoleMate, a non-invasive melanoma screening device early detection of skin cancer. Its products are used by practitioners in clinics, academic facilities, and hospitals as well as by professional athletes and sports teams for the treatment of arthritis, strains, sprains, carpal tunnel syndrome, dental pain, and tissue repair. The company sells its products to medical equipment dealers primarily in Canada, the United States, Europe, and Asia. MedX Health Corp. was incorporated in 1999 and is headquartered in Mississauga, Canada.

Founded in 1999

medx health corp (MDX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$30.0K
Chief Financial Officer
Total Annual Compensation: C$7.5K
Chief Operating Officer
Total Annual Compensation: C$147.8K
Compensation as of Fiscal Year 2013.

medx health corp (MDX) Key Developments

MedX Health Corp. Signs Exclusive Distribution Agreement in Australia and New Zealand

MedX Health Corp. signed an exclusive distribution agreement with one of Australia's and New Zealand's leading providers of medical, surgical and healthcare products to all sectors of these healthcare markets.

MedX Health Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

MedX Health Corp. reported earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $295,247 for the third quarter of 2014, or 270% of the prior year's sales level of $109,296 in 2013, an increase of $185,951. Of the increase, $108,358 was from the company's SIAscopy product line, with the rest of the increase from its therapeutic laser products. The company reported income for the three months ended September 30, 2014 of $342,733, or $0.00 per share, compared with a loss of $362,456, or $0.01 per share for the three months ended September 30, 2013. Income for the quarter was due to higher sales, and also from the reversal of previously recorded liabilities. For the nine months, the company reported income of $64,029, or $0.00 per share, compared with a loss of $885,935 or $0.02 per share for the 2013 period. Revenues of $673,038 for the first nine months of 2014 were 60% higher than revenue of $419,090 in 2013.

MedX Health Corp. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

MedX Health Corp. announced earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported loss of $9,972, or $0.00 per share compared with a loss of $174,807 or $0.00 per share for the three months ended June 30, 2013. The lower loss resulted from a debt settlement gain of $261,363 during the second quarter. Revenues were $220,019 were higher than revenue of $190,366 in 2013, due to increased revenue from the Company's SIAscopy product line. For the six months, the company reported a loss of $278,704, or $0.00 per share compared with a loss of $523,477 or $0.01 per share for the 2013 period. Revenues were $377,791 against $309,794 for the same period a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDX:CN C$0.06 CAD 0.00

MDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.85 USD 0.00
Cascade Technologies Corp $0.0060 USD 0.00
Verisante Technology Inc C$0.10 CAD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDX HEALTH CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at